Team:Caltech/Biosafety
From 2008.igem.org
RobertOvadia (Talk | contribs) |
RobertOvadia (Talk | contribs) |
||
Line 5: | Line 5: | ||
__NOTOC__ | __NOTOC__ | ||
==General Concerns== | ==General Concerns== | ||
- | There are a few risks in probiotic engineering that may prevent or delay our system from being implemented in humans. One common risk is increasing the chance of bacterial sepsis for those who have an immune deficiency. A few other risk factors include premature infants, CVC (central venous catheter), cardiac vascular disease, and diarrhea. <sup>1</sup> We are also unsure of the effects that they could play a role in metabolic activities, and there could be unknown effects | + | There are a few risks in probiotic engineering that may prevent or delay our system from being implemented in humans. One common risk is increasing the chance of bacterial sepsis for those who have an immune deficiency. A few other risk factors include premature infants, CVC (central venous catheter), cardiac vascular disease, and diarrhea. <sup>1</sup> We are also unsure of the effects that they could play a role in metabolic activities, and there could be unknown effects in implementing probiotics in humans. In addition, if we plan to supplement our strain with antibiotics for it to survive longer in the gut, such resistance may pass over into pathogenic strains which may cause future problems for the host. The concern of introducing foreign genes into the gut is described below for each individual project. |
==Subproject Concerns== | ==Subproject Concerns== |
Revision as of 04:52, 28 October 2008
People
|
Biosafety Concerns
General ConcernsThere are a few risks in probiotic engineering that may prevent or delay our system from being implemented in humans. One common risk is increasing the chance of bacterial sepsis for those who have an immune deficiency. A few other risk factors include premature infants, CVC (central venous catheter), cardiac vascular disease, and diarrhea. 1 We are also unsure of the effects that they could play a role in metabolic activities, and there could be unknown effects in implementing probiotics in humans. In addition, if we plan to supplement our strain with antibiotics for it to survive longer in the gut, such resistance may pass over into pathogenic strains which may cause future problems for the host. The concern of introducing foreign genes into the gut is described below for each individual project. Subproject ConcernsOxidative Burst
Phage Pathogen DefenseLactose Intolerance
Vitamin ProductionPopulation Variation
References
|